The Biology of Dendritic Cells and HIV Infection
Editat de Sandra Gessani, Filippo Belardellien Limba Engleză Paperback – 18 sep 2014
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 938.22 lei 6-8 săpt. | |
| Springer Us – 18 sep 2014 | 938.22 lei 6-8 săpt. | |
| Hardback (1) | 942.24 lei 6-8 săpt. | |
| Springer Us – 6 feb 2007 | 942.24 lei 6-8 săpt. |
Preț: 938.22 lei
Preț vechi: 1144.16 lei
-18% Nou
Puncte Express: 1407
Preț estimativ în valută:
179.61€ • 186.97$ • 147.86£
179.61€ • 186.97$ • 147.86£
Carte tipărită la comandă
Livrare economică 01-15 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781489998293
ISBN-10: 1489998292
Pagini: 576
Ilustrații: XXV, 544 p.
Dimensiuni: 155 x 235 x 30 mm
Greutate: 0.79 kg
Ediția:2007
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1489998292
Pagini: 576
Ilustrații: XXV, 544 p.
Dimensiuni: 155 x 235 x 30 mm
Greutate: 0.79 kg
Ediția:2007
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
V-ar putea interesa
-
Immunology at a Glance 10eJ Playfair-5%Preț: 247.92 lei260.97 lei -
-9%Preț: 768.59 lei844.61 lei -
An Epidemic of Absence: A New Way of Understanding Allergies and Autoimmune DiseasesMoises Velasquez-Manoff-5%Preț: 108.99 lei114.72 lei -
BRS Microbiology and ImmunologyLouise Hawley MD-19%Preț: 334.34 lei410.51 lei -
-27%Preț: 1399.78 lei1920.74 lei -
Tumor Necrosis FactorAgueda Escarra-27%Preț: 593.23 lei814.36 lei -
Visualizing ImmunityDorian McGavern-5%Preț: 1391.82 lei1465.08 lei -
Allergy in PracticeJohannes Ring-5%Preț: 821.06 lei864.28 lei -
Immunology of the Female Genital TractErnst Rainer Weissenbacher-5%Preț: 717.91 lei755.69 lei -
Biotechnology of Hairy Root SystemsPauline M Doran-5%Preț: 1379.86 lei1452.49 lei
Public țintă
ResearchDescriere
Dendritic cells play the most vital part in inducing anti-viral immune responses in HIV and AIDS among many other viruses. Research on dendritic cells (DCs) is emerging as a fundamental aspect for the comprehension of the mechanisms underlying the pathogenesis of viral diseases as well as for the progress on the development of prophylactic and therapeutic vaccines.
This volume focuses on the role of DCs in the pathogenesis and immunity of HIV-1 infection. It has recently been clarified that DCs are important targets and reservoirs of HIV and may play an important role in virus spreading to T cells. Interestingly, HIV can exploit many of the cellular processes responsible for the generation and regulation of the adaptive immune responses to gain access to its main target cells, i.e. the CD4+ T lymphocytes. Thus, the central role of DCs in stimulating T cell activation not only provides a route for viral transmission, but also represents a vulnerable point at which HIV-1 can interfere with the initiation of primary T cell immunity.
Recent studies have revealed that several HIV proteins can profoundly influence the phenotype and functions of DCs even in the absence of a productive infection, often resulting in an abnormal immune response. While this knowledge has resulted in the identification of some major mechanisms involved in the pathogenesis of HIV-1 infection, the recent progress on DC biology has opened perspectives in the research on new adjuvants (selectively acting on DCs) and on novel strategies for the in vivo targeting of antigens to DCs, which appear to be highly relevant for the development of HIV vaccines. Of note, defects in the number and functions of DCs have been observed in the course of HIV infection and during disease progression, thus suggesting that DCs play an important role in the immune control of viral replication and virus-induced dysfunctions. The development of therapeutic vaccination strategies to be combined with HAART is thought as an important step for an effective control of HIV infection in patients. In this context, the use of autologous DCs may represent an attracting strategy. Notably, DCs are now regarded as a valuable approach for the development of cancer vaccines and several clinical trials have explored the efficacy of different DC preparations as cellular adjuvants in inducing a potentially protective immune response. Recent data in animal models provide the background for the clinical testing of DC-based vaccines in HIV-1-infected patients. Now that we start to understand the complex interactions between HIV and DCs in the pathogenesis of AIDS and we are learning how to prepare potentially effective DCs from lessons on cancer vaccines, we may reasonably assume that DC-based therapeutic vaccines can represent a topic of increasing interest in protocols of clinical immunotherapy of HIV-1-infected patients.
This volume focuses on the role of DCs in the pathogenesis and immunity of HIV-1 infection. It has recently been clarified that DCs are important targets and reservoirs of HIV and may play an important role in virus spreading to T cells. Interestingly, HIV can exploit many of the cellular processes responsible for the generation and regulation of the adaptive immune responses to gain access to its main target cells, i.e. the CD4+ T lymphocytes. Thus, the central role of DCs in stimulating T cell activation not only provides a route for viral transmission, but also represents a vulnerable point at which HIV-1 can interfere with the initiation of primary T cell immunity.
Recent studies have revealed that several HIV proteins can profoundly influence the phenotype and functions of DCs even in the absence of a productive infection, often resulting in an abnormal immune response. While this knowledge has resulted in the identification of some major mechanisms involved in the pathogenesis of HIV-1 infection, the recent progress on DC biology has opened perspectives in the research on new adjuvants (selectively acting on DCs) and on novel strategies for the in vivo targeting of antigens to DCs, which appear to be highly relevant for the development of HIV vaccines. Of note, defects in the number and functions of DCs have been observed in the course of HIV infection and during disease progression, thus suggesting that DCs play an important role in the immune control of viral replication and virus-induced dysfunctions. The development of therapeutic vaccination strategies to be combined with HAART is thought as an important step for an effective control of HIV infection in patients. In this context, the use of autologous DCs may represent an attracting strategy. Notably, DCs are now regarded as a valuable approach for the development of cancer vaccines and several clinical trials have explored the efficacy of different DC preparations as cellular adjuvants in inducing a potentially protective immune response. Recent data in animal models provide the background for the clinical testing of DC-based vaccines in HIV-1-infected patients. Now that we start to understand the complex interactions between HIV and DCs in the pathogenesis of AIDS and we are learning how to prepare potentially effective DCs from lessons on cancer vaccines, we may reasonably assume that DC-based therapeutic vaccines can represent a topic of increasing interest in protocols of clinical immunotherapy of HIV-1-infected patients.
Cuprins
General Aspects of Dendritic Cell Biology, Functions, and Clinical Application.- Dendritic Cell Biology: Subset Heterogeneity and Functional Plasticity.- Dendritic Cells and Their Role in Linking Innate and Adaptive Immune Responses.- Dendritic Cell and Pathogen Interactions in the Subversion of Protective Immunity.- Dendritic Cells as Keepers of Peripheral Tolerance.- Adjuvants, Dendritic Cells, and Cytokines: Strategies for Enhancing Vaccine Efficacy.- Ex Vivo–Generated Dendritic Cells for ClinicalTrials versus In Vivo Targeting to Dendritic Cells: Critical Issues.- General Aspects of the Pathogenesis and Immune Response to HIV-1 Infection.- Immunopathogenesis of HIV Infection.- Innate Cellular Immune Responses in HIV Infection.- Adaptative Immune Responses in HIV-1 Infection.- Dendritic Cells and HIV Interactions and Their Role in Pathogenesis and Immunity.- Binding and Uptake of HIV by Dendritic Cellsand Transfer to T Lymphocytes: Implicationsfor Pathogenesis.- Loss, Infection, and Dysfunction of Dendritic Cells in HIV Infection.- HIV Exploitation of DC Biology to Subvertthe Host Immune Response.- Cross-Presentation by Dendritic Cells: Rolein HIV Immunity and Pathogenesis.- Immunotherapy of HIV Infection: Dendritic Cells as Targets and Tools.
Textul de pe ultima copertă
This comprehensive volume, written by experts in the field, is the first to address the biology of dendritic cells (DCs) in an integrated fashion, in the context of HIV infection and immunity. The book brings together the most recent information related to the biology of DCs and their role in the pathogenesis and immunity of HIV-1 infection. Recent research in immunology has revealed the key importance of DCs in the regulation of the immune response to infections and that DCs are important targets and reservoirs of HIV, playing a critical role in several aspects of viral pathogenesis and immunity. The Biology of Dendritic Cells and HIV Infection is an ideal book for researchers, clinicians, physicians, and graduate students in the fields of basic and applied immunology, virology, cell biology and vaccine development.
Caracteristici
The only comprehensive volume on pathogenesis and immunity of Dendritic Cells that also focuses on HIV